SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-027692
Filing Date
2019-08-01
Accepted
2019-08-01 07:01:46
Documents
71
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q syrs-10q_20190630.htm 10-Q 2247357
2 EX-31.1 syrs-ex311_10.htm EX-31.1 17533
3 EX-31.2 syrs-ex312_8.htm EX-31.2 17501
4 EX-32.1 syrs-ex321_6.htm EX-32.1 7412
5 EX-32.2 syrs-ex322_7.htm EX-32.2 7511
  Complete submission text file 0001564590-19-027692.txt   7670606

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT syrs-20190630.xml EX-101.INS 1630038
7 XBRL TAXONOMY EXTENSION SCHEMA syrs-20190630.xsd EX-101.SCH 54055
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syrs-20190630_cal.xml EX-101.CAL 52463
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syrs-20190630_def.xml EX-101.DEF 184052
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20190630_lab.xml EX-101.LAB 421725
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20190630_pre.xml EX-101.PRE 352156
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37813 | Film No.: 19990866
SIC: 2834 Pharmaceutical Preparations